Skip to main content
Top
Published in: Lung 3/2016

01-06-2016

Factors Associated with Depression in COPD: A Multicenter Study

Authors: Carlos Martinez Rivera, Joaquín Costan Galicia, Bernardino Alcázar Navarrete, Cayo Garcia-Polo, Luis Alberto Ruiz Iturriaga, Alberto Herrejón, Jose Antonio Ros Lucas, Patricia García-Sidro, Gema Tirado-Conde, Jose Luis López-Campos, Sagrario Mayoralas Alises, Javier de Miguel-Díez, Cristina Esquinas, Marc Miravitlles

Published in: Lung | Issue 3/2016

Login to get access

Abstract

Introduction

Depression is a prevalent comorbidity in COPD and has an impact on the prognosis of these patients, thereby making it important to study the factors associated with depression in patients with COPD.

Method

A multicenter, observational and cross-sectional study was conducted to study the factors associated with depression in patients with COPD measured by the hospital anxiety and depression (HAD) questionnaire. We analyzed anthropometric variables and the number of exacerbations in the previous year and calculated the 6-min walking test and the body mass index, airflow obstruction, dyspnea, and exercise (BODE) index. All the patients completed the quality of life EQ-5D and the LCADL physical activity questionnaires. The relationship of these variables with depression was evaluated with two multiple logistic regression models.

Results

One hundred fifteen patients were evaluated (93 % male) with a mean age of 66.9 years (SD 8.8) and a mean FEV1 % of 44.4 % (SD 15.7 %). 24.3 % presented symptoms of depression (HAD-D > 8). These latter patients had worse lung function, greater dyspnea, reduced exercise capacity, a higher score in the BODE index, poorer quality of life, reduced physical activity, and more exacerbations. In the first logistic regression model, quality of life and the BODE index were associated with depression (AUC: 0.84; 0.74–0.94). In the second model including the variables in the BODE index, quality of life and dyspnea measured with the MRC scale (AUC: 0.87; 0.79–0.95) were associated with depression.

Conclusions

Nearly one-quarter of the patients with COPD in this study presented clinically significant depression associated with worse quality of life, reduced exercise capacity, greater dyspnea, and a higher score in the BODE index.
Literature
2.
go back to reference Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868CrossRefPubMed Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868CrossRefPubMed
3.
go back to reference Nishimura K, Izumi T, Tsukino M, Oga T (2002) on behalf of the Kansai COPD Registry and Research Group in Japan. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121(5):1434–1440CrossRefPubMed Nishimura K, Izumi T, Tsukino M, Oga T (2002) on behalf of the Kansai COPD Registry and Research Group in Japan. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121(5):1434–1440CrossRefPubMed
4.
go back to reference Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61:772–778CrossRefPubMedPubMedCentral Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61:772–778CrossRefPubMedPubMedCentral
5.
go back to reference Celli BR, Cote CG, Marín JM et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012CrossRefPubMed Celli BR, Cote CG, Marín JM et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012CrossRefPubMed
6.
go back to reference Miravitlles M, Price D, Rabe K, Schmidt H, Metzdorf N, Celli B (2015) Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J ChronObstPulm Dis 10:549–564 Miravitlles M, Price D, Rabe K, Schmidt H, Metzdorf N, Celli B (2015) Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J ChronObstPulm Dis 10:549–564
7.
go back to reference Haro JM, Palacín C, Vilagut G et al (2006) Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Med Clin (Barc) 126:445–451CrossRef Haro JM, Palacín C, Vilagut G et al (2006) Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Med Clin (Barc) 126:445–451CrossRef
8.
go back to reference Al-Shair K, Dockry R, Mallia-Milanes B et al (2009) Depression and its relatihonship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 102:1572–1579CrossRef Al-Shair K, Dockry R, Mallia-Milanes B et al (2009) Depression and its relatihonship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 102:1572–1579CrossRef
9.
go back to reference Schane RE, Woodruff PG, Dinno A et al (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 23(11):1757e62CrossRef Schane RE, Woodruff PG, Dinno A et al (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 23(11):1757e62CrossRef
10.
go back to reference Ng TP, Niti M, Tan WC et al (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60e7CrossRef Ng TP, Niti M, Tan WC et al (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60e7CrossRef
11.
go back to reference van Manen JG, Bindels PJE, Dekker FW et al (2002) Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57:412–416CrossRefPubMedPubMedCentral van Manen JG, Bindels PJE, Dekker FW et al (2002) Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57:412–416CrossRefPubMedPubMedCentral
12.
go back to reference Yohannes AM, Roomi J, Baldwin RC, Connolly MJ (1998) Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing 27:155e60 Yohannes AM, Roomi J, Baldwin RC, Connolly MJ (1998) Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing 27:155e60
13.
go back to reference Kim KU, Park HK, Jung HY et al (2014) Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung 192:243–249CrossRefPubMed Kim KU, Park HK, Jung HY et al (2014) Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung 192:243–249CrossRefPubMed
14.
go back to reference Hanania N, Müllerova H, Locantore W, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183:604–611CrossRefPubMed Hanania N, Müllerova H, Locantore W, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183:604–611CrossRefPubMed
15.
go back to reference Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C (2014) Factors associated with depression and severe depression in patients with COPD. Respir Med 108:1615–1625CrossRefPubMed Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C (2014) Factors associated with depression and severe depression in patients with COPD. Respir Med 108:1615–1625CrossRefPubMed
16.
go back to reference Jordan N, Lee TA, Valenstein M, Weiss KB (2007) Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med 22:1447–1452CrossRefPubMedPubMedCentral Jordan N, Lee TA, Valenstein M, Weiss KB (2007) Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med 22:1447–1452CrossRefPubMedPubMedCentral
17.
go back to reference Xu W, Collet JP, Shapiro S et al (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178:913–920CrossRefPubMed Xu W, Collet JP, Shapiro S et al (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178:913–920CrossRefPubMed
18.
go back to reference Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA (2008) Relationship between depression and exacerbations in COPD. Eur Respir J 32:53–60CrossRefPubMed Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA (2008) Relationship between depression and exacerbations in COPD. Eur Respir J 32:53–60CrossRefPubMed
19.
go back to reference Dahlen I, Janson C (2002) Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 122:1633–1637CrossRefPubMed Dahlen I, Janson C (2002) Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 122:1633–1637CrossRefPubMed
20.
go back to reference Stage KB, Middelboe T, Pisinger C (2005) Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand 111:320–323CrossRefPubMed Stage KB, Middelboe T, Pisinger C (2005) Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand 111:320–323CrossRefPubMed
21.
go back to reference Dalal A, Shah M, Lunacsek O, Hanania NA (2011) Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD 8(4):293–299CrossRefPubMed Dalal A, Shah M, Lunacsek O, Hanania NA (2011) Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD 8(4):293–299CrossRefPubMed
22.
go back to reference Alcázar B, García-Polo C, Herrejon A et al (2012) Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 48(3):70–76CrossRefPubMed Alcázar B, García-Polo C, Herrejon A et al (2012) Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 48(3):70–76CrossRefPubMed
23.
go back to reference García-Polo C, Alcázar-Navarrete B, Ruiz-Iturriaga LA, Herrejón A, Ros-Lucas JA, García-Sidro P et al (2012) Factors associated with high resource utilisation among COPD patients. Respir Med 106:1734–1742CrossRefPubMed García-Polo C, Alcázar-Navarrete B, Ruiz-Iturriaga LA, Herrejón A, Ros-Lucas JA, García-Sidro P et al (2012) Factors associated with high resource utilisation among COPD patients. Respir Med 106:1734–1742CrossRefPubMed
24.
go back to reference Herrero MJ, Blanch J, Peri JM et al (2003) A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 25:277–283CrossRefPubMed Herrero MJ, Blanch J, Peri JM et al (2003) A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 25:277–283CrossRefPubMed
25.
go back to reference Bestall JC, Paul EA, Garrod R et al (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability inpatients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentral Bestall JC, Paul EA, Garrod R et al (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability inpatients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentral
26.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
27.
go back to reference Badia X, Roset M, Monserrat S et al (1999) La versión española del EuroQoL: descripción y aplicaciones. Med Clin (Barc) 112:79–86 Badia X, Roset M, Monserrat S et al (1999) La versión española del EuroQoL: descripción y aplicaciones. Med Clin (Barc) 112:79–86
28.
go back to reference Vilaró J, Gimeno E, Sánchez Férez N et al (2007) Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 29:326–332CrossRef Vilaró J, Gimeno E, Sánchez Férez N et al (2007) Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 29:326–332CrossRef
29.
go back to reference Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2014) Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 50(Suppl 1):1–16PubMed Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2014) Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 50(Suppl 1):1–16PubMed
30.
go back to reference Iguchi A, Senjyu H, Hayashi Y et al (2013) Relationhip between depression in patients with COPD and the percent of predicted FEV1, BODE Index, and Health-Related Quality of Life. Respir Care 58(2):334–339PubMed Iguchi A, Senjyu H, Hayashi Y et al (2013) Relationhip between depression in patients with COPD and the percent of predicted FEV1, BODE Index, and Health-Related Quality of Life. Respir Care 58(2):334–339PubMed
31.
go back to reference Cleland JA, Lee AJ, Hall S (2007) Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 24:217–223CrossRefPubMed Cleland JA, Lee AJ, Hall S (2007) Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 24:217–223CrossRefPubMed
32.
go back to reference Gudmundsson G, GislasonTh Janson Ch et al (2006) Depression, anxiety and health status after hospitalization for COPD: a multicentre study in the Nordic countries. Respir Med 100:87–93CrossRefPubMed Gudmundsson G, GislasonTh Janson Ch et al (2006) Depression, anxiety and health status after hospitalization for COPD: a multicentre study in the Nordic countries. Respir Med 100:87–93CrossRefPubMed
33.
go back to reference Mishima M, Oku Y, Muro Sh et al (1996) Relationship between dyspnea in daily life and psycho-physiologic state in patients with chronic obstructive pulmonary disease during long-term domiciliary oxygen therapy. Intern Med 35:453–458CrossRefPubMed Mishima M, Oku Y, Muro Sh et al (1996) Relationship between dyspnea in daily life and psycho-physiologic state in patients with chronic obstructive pulmonary disease during long-term domiciliary oxygen therapy. Intern Med 35:453–458CrossRefPubMed
34.
go back to reference Pooler A, Beech R (2014) Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obst Pulm Dis 9:315–330CrossRef Pooler A, Beech R (2014) Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obst Pulm Dis 9:315–330CrossRef
35.
go back to reference Di Marco F, Terraneo S, Roggi MA et al (2014) Physical actvity impairment in depressed COPD subjects. Respir Care 59:726–734CrossRefPubMed Di Marco F, Terraneo S, Roggi MA et al (2014) Physical actvity impairment in depressed COPD subjects. Respir Care 59:726–734CrossRefPubMed
36.
go back to reference Miravitlles M, Cantoni J, Naberan K (2014) Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung 192(2):259–265CrossRefPubMed Miravitlles M, Cantoni J, Naberan K (2014) Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung 192(2):259–265CrossRefPubMed
37.
go back to reference Lou P, Zhu Y, Chen P et al (2012) Prevalence and correlations with depression, anxiety, and other feratures in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 12:53CrossRefPubMedPubMedCentral Lou P, Zhu Y, Chen P et al (2012) Prevalence and correlations with depression, anxiety, and other feratures in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 12:53CrossRefPubMedPubMedCentral
38.
go back to reference Funk GC, Kirchheiner K, Bughuber OC et al (2009) BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD—a cross-sectional study. Respir Res 10:1CrossRefPubMedPubMedCentral Funk GC, Kirchheiner K, Bughuber OC et al (2009) BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD—a cross-sectional study. Respir Res 10:1CrossRefPubMedPubMedCentral
39.
go back to reference Tetikkurt C, Ozdemir I, Tetikkurt S, Yilmaz N et al (2011) Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multdiscip Respir Med 6(4):226–231CrossRef Tetikkurt C, Ozdemir I, Tetikkurt S, Yilmaz N et al (2011) Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multdiscip Respir Med 6(4):226–231CrossRef
40.
go back to reference Balcells E, Gea J, Ferrer J et al (2010) Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 8:108CrossRefPubMedPubMedCentral Balcells E, Gea J, Ferrer J et al (2010) Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 8:108CrossRefPubMedPubMedCentral
41.
go back to reference Lacasse Y, Rousseau L, Maltais F (2001) Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 21(2):80–86CrossRefPubMed Lacasse Y, Rousseau L, Maltais F (2001) Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 21(2):80–86CrossRefPubMed
42.
go back to reference Hajiro T, Nishimura K, Tsukino M et al (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 94(9):841–846CrossRefPubMed Hajiro T, Nishimura K, Tsukino M et al (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 94(9):841–846CrossRefPubMed
43.
go back to reference Di Marco F, Verga M, Reggente M et al (2006) Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 100:1767–1774CrossRefPubMed Di Marco F, Verga M, Reggente M et al (2006) Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 100:1767–1774CrossRefPubMed
44.
go back to reference Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR (2007) Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 86:30–36CrossRefPubMed Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR (2007) Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 86:30–36CrossRefPubMed
45.
go back to reference Kozora E, Tran ZV, Make B (2002) Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 22:426–430CrossRefPubMed Kozora E, Tran ZV, Make B (2002) Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 22:426–430CrossRefPubMed
46.
go back to reference Eiser N, Harte R, Spiros K et al (2005) Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2:233–241CrossRefPubMed Eiser N, Harte R, Spiros K et al (2005) Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2:233–241CrossRefPubMed
47.
go back to reference Borson S, McDonald GJ, Gayle T et al (1992) Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201CrossRefPubMed Borson S, McDonald GJ, Gayle T et al (1992) Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201CrossRefPubMed
48.
go back to reference Maurer J, Rebbapragada V, Borson S et al (2008) ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research areas. Chest 134(Suppl 4):43S–56SCrossRefPubMedPubMedCentral Maurer J, Rebbapragada V, Borson S et al (2008) ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research areas. Chest 134(Suppl 4):43S–56SCrossRefPubMedPubMedCentral
49.
go back to reference Anderson IM, Nutt DJ, Deakin JF (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 14(1):3–20CrossRefPubMed Anderson IM, Nutt DJ, Deakin JF (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 14(1):3–20CrossRefPubMed
Metadata
Title
Factors Associated with Depression in COPD: A Multicenter Study
Authors
Carlos Martinez Rivera
Joaquín Costan Galicia
Bernardino Alcázar Navarrete
Cayo Garcia-Polo
Luis Alberto Ruiz Iturriaga
Alberto Herrejón
Jose Antonio Ros Lucas
Patricia García-Sidro
Gema Tirado-Conde
Jose Luis López-Campos
Sagrario Mayoralas Alises
Javier de Miguel-Díez
Cristina Esquinas
Marc Miravitlles
Publication date
01-06-2016
Publisher
Springer US
Published in
Lung / Issue 3/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9862-7

Other articles of this Issue 3/2016

Lung 3/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.